Carbamazepine Tablet, Extended Release
Product Images NDC 70518-3773

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Carbamazepine (NDC 70518-3773). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Carbamazepine 100 mg extended-release tablets in a box of 100 by RemedyRepack Inc. The label features dosage strength, tablet form, a barcode, QR code, manufacturer information (Cadista Pharma, Inc.), warnings to keep out of reach of children, and a note that tablets must be swallowed whole. Directions advise consulting the package insert.*

FDA Label Image

Mm2 (Carbamazepine 100mg 70518 3773 01)

Carbamazepine 100 mg extended-release oral tablet single unit packaging label by RemedyRepack Inc. The label includes dosage strength, tablet form, quantity of one tablet, barcode, QR code, manufacturer Cadista Pharma, and storage and usage warnings.*

FDA Label Image

Image Description (Carbamazepine Structure)

Chemical structure of carbamazepine, showing a dibenzazepine ring with an amide group attached to the nitrogen atom.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.